Vitalhub Q2 Earnings Call Highlights

Impact · against what's priced in

Vitalhub's crossing of the CAD 100M ARR threshold and strong cash position provide a positive valuation catalyst, though this is partially offset by specific revenue attrition in the UK. Palantir sees a marginal positive as its NHS platform is actively displacing competing niche solutions.

VHI+0.40

No priced-in read yet

In context

Crossing the CAD 100 million ARR milestone (reaching CAD 101.5M) and maintaining over CAD 120 million in cash suggests high scalability and M&A optionality, though UK SHREWD renewals are under pressure from Palantir.

Read from the article alone

• PLTR▲22%
• m and a▲14%
• earnings▲4%
• ai
• VHI
• cross selling
• digital health